Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10


Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features.

Solis LM, Behrens C, Dong W, Suraokar M, Ozburn NC, Moran CA, Corvalan AH, Biswal S, Swisher SG, Bekele BN, Minna JD, Stewart DJ, Wistuba II.

Clin Cancer Res. 2010 Jul 15;16(14):3743-53. doi: 10.1158/1078-0432.CCR-09-3352. Epub 2010 Jun 9.


Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation.

Raso MG, Behrens C, Herynk MH, Liu S, Prudkin L, Ozburn NC, Woods DM, Tang X, Mehran RJ, Moran C, Lee JJ, Wistuba II.

Clin Cancer Res. 2009 Sep 1;15(17):5359-68. doi: 10.1158/1078-0432.CCR-09-0033. Epub 2009 Aug 25.


HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors.

Sun M, Behrens C, Feng L, Ozburn N, Tang X, Yin G, Komaki R, Varella-Garcia M, Hong WK, Aldape KD, Wistuba II.

Clin Cancer Res. 2009 Aug 1;15(15):4829-37. doi: 10.1158/1078-0432.CCR-08-2921. Epub 2009 Jul 21.


Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung.

Prudkin L, Liu DD, Ozburn NC, Sun M, Behrens C, Tang X, Brown KC, Bekele BN, Moran C, Wistuba II.

Mod Pathol. 2009 May;22(5):668-78. doi: 10.1038/modpathol.2009.19. Epub 2009 Mar 6.


Epidermal growth factor receptor abnormalities in the pathogenesis and progression of lung adenocarcinomas.

Tang X, Varella-Garcia M, Xavier AC, Massarelli E, Ozburn N, Moran C, Wistuba II.

Cancer Prev Res (Phila). 2008 Aug;1(3):192-200. doi: 10.1158/1940-6207.CAPR-08-0032.


Loss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancer.

Prudkin L, Behrens C, Liu DD, Zhou X, Ozburn NC, Bekele BN, Minna JD, Moran C, Roth JA, Ji L, Wistuba II.

Clin Cancer Res. 2008 Jan 1;14(1):41-7. doi: 10.1158/1078-0432.CCR-07-1252.


KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer.

Massarelli E, Varella-Garcia M, Tang X, Xavier AC, Ozburn NC, Liu DD, Bekele BN, Herbst RS, Wistuba II.

Clin Cancer Res. 2007 May 15;13(10):2890-6.


Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions.

Tang X, Liu D, Shishodia S, Ozburn N, Behrens C, Lee JJ, Hong WK, Aggarwal BB, Wistuba II.

Cancer. 2006 Dec 1;107(11):2637-46.


Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma.

Nigro JM, Misra A, Zhang L, Smirnov I, Colman H, Griffin C, Ozburn N, Chen M, Pan E, Koul D, Yung WK, Feuerstein BG, Aldape KD.

Cancer Res. 2005 Mar 1;65(5):1678-86.


Is prey predation risk influenced more by increasing predator density or predator species richness in stream enclosures?

Vance-Chalcraft HD, Soluk DA, Ozburn N.

Oecologia. 2004 Mar;139(1):117-22. Epub 2004 Jan 15.


Supplemental Content

Loading ...
Support Center